Seattle conference to focus on trauma and addiction treatment

The incidence of trauma and abuse has truly reached epidemic proportions, and those who suffer trauma sometimes turn to alcohol or other drugs to manage post-traumatic stress symptoms like nightmares, anxiety, insomnia, and dissociation.  

That's why Hazelden, the nation's leading provider of addiction recovery services and information, will host a daylong conference on "Treating Trauma and Addiction," October 5 in Seattle at the Marriott Waterfront.  The conference will bring together clinicians, counselors and other healing professionals to explore approaches to the problem of trauma sufferers, www.hazelden.org/traumaconference.

Presenters at the conference will include New York Times best-selling author William C. Moyers, vice president of Public Affairs and Community Relations for Hazelden and author of the upcoming "Now What? An Insider's Guide to Addiction and Recovery"; Stephanie S. Covington, Ph.D., co-director of the Institute for Relational Development and the Center for Gender and Justice, and an expert in the field of women, trauma and addiction; and Laura Ferguson, M.D., an addiction psychiatrist at Hazelden in Springbrook, Ore., which specializes in treating trauma and addiction.

SOURCE Hazelden

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption